Research, News & Discoveries

High school student Benjamin Gordon, former Marnett lab intern, has been named a top scholar in the Regeneron Science Talent Search 2024, the oldest science and math competition for high school seniors in the U.S. Read More

We extend congratulations to our many community members who were recently promoted or received new appointments. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

The “Molecular Muse” exhibit is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program. The program was recently awarded a fourth year of funding from the Burroughs Wellcome Fund. Read More

Avenir Award funding from the National Institute on Drug Abuse recognizes research that represents “the future of addiction science.” Brown’s research is creating an AI-experiment feedback loop that will help optimize painkilling drugs to be less addictive. Read More

Phase I clinical trial of a drug was successfully completed at the Warren Center for Neuroscience Drug Discovery, with promise to treat Alzheimer’s and other neurodegenerative diseases. The compound, named VU319, is the first Vanderbilt end-to-end drug discovery effort related to memory loss, starting from the earliest basic science research through human clinical trials. Read More

Machine learning and OpenFold authority Mohammed AlQuraishi to present the Vanderbilt Basic Sciences Apex Lecture on January 29. Read More

Join the next Lab-to-Table conversation, “Beyond Addiction: Therapeutic Developments and Societal Impact” on Jan. 24 at 11:30 a.m. CT. Read More

The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read More

Researchers in the lab of Vivian Weiss, assistant professor of pathology, microbiology, and immunology, recently published a review article in Cancer Research that describes the role of the Wnt pathway in TAMs and tumor biology. Read More

Jeffrey Spraggins, associate professor of cell and developmental biology, biochemistry, and chemistry, has been named director of the Mass Spectrometry Research Center. He succeeds Richard Caprioli, Stanford Moore Chair in Biochemistry, who established the MSRC in 1998 and who is retiring this summer. Read More